Sequential analysis of CD34+and CD34-cell subsets in peripheral blood and leukapheresis products from breast cancer patients mobilized with SCF plus G-CSF and cyclophosphamide.

被引：0
|
作者：
Menéndez, PP
Prósper, FF
Bueno, CC
Arbona, C
García-Conde, JJ
San Miguel, JFJF
Sola, C
Hornedo, J
Cortés-Funes, H
Orfao, AA
机构：
[1] Univ Salamanca, E-37008 Salamanca, Spain
[2] Univ Hosp, Valencia, Spain
[3] Univ Hosp, Salamanca, Spain
[4] Hosp, Barcelona, Spain
[5] Hosp, Madrid, Spain
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5059
引用
收藏
页码：304B / 304B
页数：1
相关论文
共 50 条
  • [31] CD34+ cell content of G-CSF mobilized peripheral blood progenitor cells correlates with ex vivo expansion potential.
    Lundell, BI
    Scott, AB
    Vredenburgh, JJ
    Smith, AK
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 707 - 707
  • [32] Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates
    Hematti, P
    Tuchman, S
    Larochelle, A
    Metzger, ME
    Donahue, RE
    Tisdale, JF
    STEM CELLS, 2004, 22 (06) : 1062 - 1069
  • [33] Quantitative and qualitative protein expression mapping of highly enriched G-CSF mobilized CD34+stem cells from peripheral blood
    Lannert, H
    Franz, T
    Eckstein, V
    Hofmann, R
    Lenze, A
    Horsch, K
    Miesala, K
    Ho, AD
    BLOOD, 2004, 104 (11) : 119B - 119B
  • [34] Analysis of surface markers on CD34+ cells, isolated from cord blood and G-CSF primed peripheral blood
    Barbosa, IL
    de Sousa, ME
    Godinho, MI
    Teixeira, AM
    Carvalhais, A
    BONE MARROW TRANSPLANTATION, 1998, 22 : S56 - S56
  • [35] Analysis of viable CD133+/CD34+AND CD34+stem cell subsets in prediction of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Hicks, C.
    CYTOTHERAPY, 2006, 8
  • [36] Autologous G-CSF-Mobilized Peripheral Blood CD34+ Cell Therapy for Diabetic Patients With Chronic Nonhealing Ulcer
    Tanaka, Rica
    Masuda, Haruchika
    Kato, Shunichi
    Imagawa, Kotaro
    Kanabuchi, Kazuo
    Nakashioya, Chie
    Yoshiba, Fumiaki
    Fukui, Tsuyoshi
    Ito, Rie
    Kobori, Michiru
    Wada, Mika
    Asahara, Takayuki
    Miyasaka, Muneo
    CELL TRANSPLANTATION, 2014, 23 (02) : 167 - 179
  • [37] Dynamic cell cycle kinetics of normal CD34+ cells and CD38+/- subsets of haemopoietic progenitor cells in G-CSF-mobilized peripheral blood
    Holm, M
    Thomsen, M
    Hoyer, M
    Hokland, P
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (04) : 1002 - 1013
  • [38] Hematopoietic Cell Transplantation of Higher CD34+Cell Doses and Specific CD34+Subsets Mobilized with Motixafortide and/or G-CSF Is Associated with Rapid Engraftment - a Post-Hoc Analysis of the Genesis Trial
    Crees, Zachary D.
    Stockerl-Goldstein, Keith E.
    Retting, Michael
    Larson, Sarah M.
    Illes, Arpad
    Milone, Giuseppe
    Martino, Massimo
    Stiff, Patrick
    Sborov, Douglas W.
    Pereira, Denise L.
    Micallef, Ivana N.
    Moreno Jimenez, Gemma
    Mikala, Gabor
    Paciello Coronel, Maria Liz
    Holtick, Udo
    Hiemenz, John W.
    Qazilbash, Muzaffar H.
    Hardy, Nancy M.
    Latif, Tahir
    Garcia-Cadenas, Irene
    Sorani, Ella
    Shemesh-Darvish, Liron
    Vainstein, Abi
    Kadosh, Shaul
    DiPersio, John F.
    BLOOD, 2021, 138
  • [39] Rituximab does not reduce CD34+cell yield in patients mobilized with etoposide plus G-CSF.
    Bolwell, BJ
    Kalaycio, M
    Sobecks, R
    Andresen, S
    Kuczkowski, E
    Rybicki, L
    Bernhard, L
    Ostendorf, H
    Koennecke, J
    Pohlman, B
    BLOOD, 2001, 98 (11) : 738A - 738A
  • [40] Phenotype of CD34+ stem cell subpopulations in peripheral blood of patients undergoing mobilization of PBSC with cyclophosphamide, etoposide and SC-70935 or G-CSF
    Klabusay, M
    Lysak, D
    Kovarova, L
    Koristek, Z
    Mayer, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S253 - S253
12345